凯姆布雷克斯(CBM)

59.99 0.00 0.0%

今开:0.0昨收:59.99
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:2.023124776E9

凯姆布雷克斯的最新讨论

用户48783635432019-01-03 17:29

【汇众医疗】$C$凯姆布雷克斯(CBM)$ $$阿维斯塔(AVA)$ 生物科技制药公司 Cambrex 以2.52亿美元收购 Avista 制药公司
该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文

洛杉矶吴明2015-07-15 23:23

$凯姆布雷克斯(CBM)$ 今年目标价:$80。原因:高速成长、新厂房及生产线即将竣工、即将增加巨无霸客户。查看全文

琬麟2015-02-07 09:21

$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文

eric08712014-02-12 00:51

$凯姆布雷克斯(CBM)$ 亲你怎么了查看全文

峰雾2011-09-11 01:13

关注$凯姆布雷克斯(CBM)$,当前价$4.86。查看全文

凯姆布雷克斯的公告

$凯姆布雷克斯(CBM)$ DEF 14A - Other definitive proxy statements Filed: 2019-03-12 AccNo: 0001564590-19-007364 Size: 1 MB 网页链接

$凯姆布雷克斯(CBM)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-03-12 AccNo: 0001564590-19-007375 Size: 182 KB 网页链接

$凯姆布雷克斯(CBM)$ 8-K/A [Amend] - Current report Filed: 2019-03-11 AccNo: 0001193125-19-069418 Size: 669 KBItem 9.01: Financial Statements and Exhibits 网页链接

$凯姆布雷克斯(CBM)$ 内部交易: 2019-02-15,EVP & COO,Cavanagh Shawn ,卖出,6769普通股, $37.60

$凯姆布雷克斯(CBM)$ 内部交易: 2019-02-15,CFO & EVP, Corp. Dev.,SARGEN GREGORY ,卖出,5802普通股, $37.45

$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-13 AccNo: 0001144204-19-007189 Size: 54 KB 网页链接

$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2019-02-13 AccNo: 0001564590-19-002749 Size: 2 MBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$凯姆布雷克斯(CBM)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-02-13 AccNo: 0001564590-19-002751 Size: 18 MB 网页链接

$凯姆布雷克斯(CBM)$ 美东时间 2019-02-13 盘前 披露财报,预期EPS 1.32 网页链接

$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2019-02-06 AccNo: 0001564590-19-002167 Size: 105 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32